Schedule a Meeting with Catalent at ISSCR Annual Meeting 2022

Date: June 15-18, 2022
Location: Moscone Center West – San Francisco, CA
Booth: 132

FEATURED SPEAKER

Boris Greber, Ph.D.
Head of Research & Development, iPCS, Catalent Cell & Gene Therapy

Session Title: GMP-Compliant iPSC lines and Differentiation Workflows for Cell Therapy
Session Date: Wednesday, June 15, 2022
Session Time: 8:15PM – 8:30PM
Abstract: Induced pluripotent stem cells (iPSCs) are emerging as a powerful starting material in regenerative medicine and cancer therapy, offering a promising allogeneic approach for a broad patient population. Our presentation will highlight key initiatives in iPSC banking and differentiation to make these therapies both process efficient and regulatory compatible.

• • Key Learnings:
    • How Catalent is developing an HLA-homozygous (HLA-h) universal cell bank from cord blood units accounting for key regulatory aspects such as donor eligibility and consent, GMP manufacturing and commercial use consent.
    • Our characterization criteria of the banks to ensure high genomic integrity, effectiveness of reprogramming and unlimited self-renewal.
    • Our initiatives to develop advanced GMP-compliant protocols are suitable for differentiating iPSCs into various cell types of medical interest including retinal pigment epithelium, mesenchymal stromal cells, natural killer cells and more.